Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
SAN DIEGO--(BUSINESS WIRE)--Nov 9, 2023--
Source: bdtonline.com
📰 Bio Statement News
Bio Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Statement. Real-time updates on events, politics, business and more.
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
09.08.2022 - Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial ...
United States Exchange Commission Development Rd Expenses Pulmonary Arterial Hypertension Quarter Ended June Cash Equivalents
Source: wallstreet-online.de
Gossamer Bio : Announces Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update - Seralutinib Phase 2 TORREY Study on track for topline readout in second half of... | August 9, 2022
United States Faheem Hasnain Bryan Giraudo Gossamer Bio Inc Exchange Commission Development Rd Expenses
Source: marketscreener.com